Accrued expenses consist of the following (in thousands): | | | | | | | | | June 30, 2026 | | December 31, 2025 | | | | | | | | Accrued clinical trial expenses | | $ | 24,283 | | $ | 14,338 | Accrued milestone payments and royalties | | | 3,698 | | | 11,767 | Accrued compensation and related benefits | | | 6,635 | | | 10,860 | Accrued commercialization costs | | | 6,956 | | | 8,205 | Accrued contract manufacturing expenses | | | 4,488 | | | 3,224 | Accrued other research and development expenses | | | 3,895 | | | 3,015 | Accrued consulting fees | | | 1,892 | | | 1,287 | Accrued professional fees | | | 798 | | | 793 | Accrued other | | | 1,551 | | | 492 | Total accrued expenses | | $ | 54,196 | | $ | 53,981 |
|